ITGR (Integer Holdings) ROE %: 3.83% (As of Mar. 2026) — 44% Below Median


ITGR Integer Holdings Corp ITGR
85 GF Score
Price $91.38
GF Value $117.19
Valuation Modestly Undervalued
! 1 Warning Sign
View Full Analysis

What is Integer Holdings ROE %?

Integer Holdings ITGR +2.05% 85 ROE % is 3.83% as of Mar. 2026, which is 44% below its 10-year median of 6.88. GuruFocus rates ITGR with a GF Score™ of 85/100 and a GF Value™ of $117.19 (Modestly Undervalued). The stock has 1 warning sign investors should review. Among 799 Medical Devices & Instruments companies, Integer Holdings ranks better than 68.09% on this metric.

ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. Integer Holdings's annualized net income for the quarter that ended in Mar. 2026 was $66 Mil. Integer Holdings's average Total Stockholders Equity over the quarter that ended in Mar. 2026 was $1,722 Mil. Therefore, Integer Holdings's annualized ROE % for the quarter that ended in Mar. 2026 was 3.83%.

The historical rank and industry rank for Integer Holdings's ROE % or its related term are showing as below:

ITGR' s ROE % Range Over the Past 10 Years
Min: 0.76   Med: 6.88   Max: 17.19
Current: 8.34

During the past 13 years, Integer Holdings's highest ROE % was 17.19%. The lowest was 0.76%. And the median was 6.88%.

ITGR's ROE % is ranked better than
68.09% of 799 companies
in the Medical Devices & Instruments industry
Industry Median: 2.42 vs ITGR: 8.34

Integer Holdings  (NYSE:ITGR) ROE % Explanation

ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.

The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:

ROE %(Q: Mar. 2026 )
=Net Income/Total Stockholders Equity
=66.024/1721.7675
=(Net Income / Revenue )*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(66.024 / 1758.32)*(1758.32 / 3411.148)*(3411.148 / 1721.7675)
=Net Margin %*Asset Turnover*Equity Multiplier
=3.75 %*0.5155*1.9812
=ROA %*Equity Multiplier
=1.93 %*1.9812
=3.83 %

With this breakdown, it is clear that if a company grows its Net Profit Margin, its Asset Turnover, or its Leverage, it can grow its ROE %.

The factors that affect a company's ROE % can also be illustrated with the five-step DuPont Analysis:

ROE %(Q: Mar. 2026 )
=Net Income/Total Stockholders Equity
=66.024/1721.7675
=(Net Income / Pre-Tax Income) * (Pre-Tax Income / Operating Income) * (Operating Income / Revenue) * (Revenue / Total Assets) * (Total Assets / Total Stockholders Equity)
= (66.024 / 81.404) * (81.404 / 141.888) * (141.888 / 1758.32) * (1758.32 / 3411.148) * (3411.148 / 1721.7675)
= Tax Burden * Interest Burden * Operating Margin % * Asset Turnover * Equity Multiplier
= 0.8111 * 0.5737 * 8.07 % * 0.5155 * 1.9812
=3.83 %

Note: The net income data used here is four times the quarterly (Mar. 2026) net income data. The Revenue data used here is four times the quarterly (Mar. 2026) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net Income is used.

Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.


Integer Holdings ROE % Related Terms


Integer Holdings ROE % Historical Data

* Premium members only.

The historical data trend for Integer Holdings's ROE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Integer Holdings ROE % Chart

Integer Holdings Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7.37 4.79 6.17 7.64 6.11

Integer Holdings Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -5.58 8.94 9.20 11.13 3.83

ITGR vs HAE, IRTC, TMDX: ROE % Comparison

For the Medical Devices subindustry, Integer Holdings's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Integer Holdings ROE % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Integer Holdings's ROE % distribution charts can be found below:

* The bar in red indicates where Integer Holdings's ROE % falls into.


ITGR
85GF Score
Integer Holdings Corp ITGR
ROE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Integer Holdings ROE % Calculation

Integer Holdings's annualized ROE % for the fiscal year that ended in Dec. 2025 is calculated as

ROE %=Net Income (A: Dec. 2025 )/( (Total Stockholders Equity (A: Dec. 2024 )+Total Stockholders Equity (A: Dec. 2025 ))/ count )
=102.808/( (1619.215+1746.643)/ 2 )
=102.808/1682.929
=6.11 %

Integer Holdings's annualized ROE % for the quarter that ended in Mar. 2026 is calculated as

ROE %=Net Income (Q: Mar. 2026 )/( (Total Stockholders Equity (Q: Dec. 2025 )+Total Stockholders Equity (Q: Mar. 2026 ))/ count )
=66.024/( (1746.643+1696.892)/ 2 )
=66.024/1721.7675
=3.83 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is four times the quarterly (Mar. 2026) net income data. ROE % is displayed in the 30-year financial page.

Frequently Asked Questions Learn more about ROE % →
What does a ROE % of 3.83% mean?
Integer Holdings (ITGR) has a ROE % of 3.83% as of Mar. 2026. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Integer Holdings and its competitors. This is 44% below median its historical median of 6.88. Over the past decade, Integer Holdings' ROE % has ranged from 0.76 to 17.19. According to the industry distribution chart, Integer Holdings ranks #255 out of 799 companies in the Medical Devices & Instruments industry, placing it in the top 31.9%.
Is Integer Holdings' ROE % too high?
Integer Holdings' current ROE % of 3.83% is 44% below median its 10-year median of 6.88. Over the past 10 years, this metric has ranged from a low of 0.76 to a high of 17.19. The Medical Devices & Instruments industry median ROE % is 2.42. Integer Holdings' value of 3.83% is 58.3% above this industry median. Based on the distribution chart, Integer Holdings ranks #255 out of 799 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Integer Holdings has a GF Score™ of 85/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Integer Holdings' ROE % compare to HAE and IRTC?
According to the Medical Devices & Instruments industry distribution chart, Integer Holdings ranks #255 out of 799 companies for ROE %. This puts Integer Holdings in the upper half of its industry. The industry median ROE % is 2.42. Integer Holdings' value of 3.83% is 58.3% above this benchmark. Historically, Integer Holdings' own ROE % has ranged from 0.76 to 17.19 over the past decade. While the company's 10-year median is 6.88 vs. the industry median of 2.42, Integer Holdings has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % for a Medical Devices & Instruments company?
The median ROE % among Medical Devices & Instruments companies is 2.42, based on 799 companies in the industry. Companies in the top quartile (top 25%) have a ROE % significantly above this median, while those in the bottom quartile fall well below. However, ROE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Integer Holdings's current ROE % of 3.83% is 58.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % mean?
A high ROE % can signal that a stock is expensive relative to its fundamentals. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Integer Holdings and its competitors. For the Medical Devices & Instruments industry, the median ROE % is 2.42 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Integer Holdings's current ROE % is 3.83%, which is 44% below median its own 10-year median of 6.88. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Integer Holdings stock overvalued right now?
Based on GuruFocus' analysis, Integer Holdings (ITGR) is currently considered Modestly Undervalued. The stock's GF Value™ is $117.19, compared to a current price of $91.38 — trading 22% below its estimated fair value. The current ROE % is 3.83%, which is 44% below median its 10-year median of 6.88 and 58.3% above the Medical Devices & Instruments industry median of 2.42. Integer Holdings' overall GF Score™ is 85/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % calculated?
ROE % is calculated from a company's financial statements. For Integer Holdings (ITGR), the current ROE % is 3.83% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Integer Holdings (ITGR) Overvalued in 2026?

Based on GuruFocus' analysis, Integer Holdings stock appears to be undervalued. The current stock price of $91.38 is trading 22% below its estimated GF Value™ of $117.19. GuruFocus considers Integer Holdings to be Modestly Undervalued.

Key valuation signals for ITGR:

  • ROE %: 3.83% (44% below median its 10-year median of 6.88)
  • GF Value™: $117.19 vs. price of $91.38 (22% below fair value)
  • GF Score™: 85/100 with 1 warning sign
  • Industry Position: 58.3% above the Medical Devices & Instruments median (#255 of 799)

No single metric tells the full story. See the ITGR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Integer Holdings Business Description

Other Exchanges WGB:Germany
Address 5830 Granite Parkway, Suite 1150, Plano, TX, USA, 75024
Integer Holdings Corp is a manufacturer of medical device components used by original equipment manufacturers in the medical industry. The firm organizes itself into one segment and derives its revenues from three product lines: Cardio & Vascular, Cardiac Rhythm Management & Neuromodulation and Other Markets. The company earns maximum of its revenue in the United States, and also has its presence in Ireland, Puerto Rico, Costa Rica, and Rest of the World.
85GF Score

Get the complete analysis for ITGR

ROE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$91.38
Price
$117.19
GF Value